These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38854314)

  • 21. Point of care real-time polymerase chain reaction-based diagnostic for Kyasanur forest disease.
    Majumdar T; Shete A; Yadav P; Patil S; Mali D; Waghmare A; Gawande P
    Int J Infect Dis; 2021 Jul; 108():226-230. PubMed ID: 34023493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The species distribution of ticks & the prevalence of Kyasanur forest disease virus in questing nymphal ticks from Western Ghats of Kerala, South India.
    Balasubramanian R; Yadav PD; Sahina S; Nadh VA
    Indian J Med Res; 2021 May; 154(5):743-749. PubMed ID: 35532592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinetics of human infection with Kyasanur Forest Disease Virus.
    Devadiga S; Arunkumar G
    J Infect; 2022 Aug; 85(2):161-166. PubMed ID: 35609707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coverage and effectiveness of Kyasanur forest disease (KFD) vaccine in Karnataka, South India, 2005-10.
    Kasabi GS; Murhekar MV; Sandhya VK; Raghunandan R; Kiran SK; Channabasappa GH; Mehendale SM
    PLoS Negl Trop Dis; 2013; 7(1):e2025. PubMed ID: 23359421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does the rise in cases of Kyasanur forest disease call for the implementation of One Health in India?
    Pattnaik S; Agrawal R; Murmu J; Kanungo S; Pati S
    IJID Reg; 2023 Jun; 7():18-21. PubMed ID: 36941826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study of the clinical manifestations and risk factors in people affected during the first Kyasanur Forest Disease outbreak in Goa, India: A mixed method study.
    Kuchelkar SP; Dias A; Gomes E; Dias L
    J Vector Borne Dis; 2024 Jan; 61(1):23-28. PubMed ID: 38648403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retrospective Study of Kyasanur Forest Disease and Deaths among Nonhuman Primates, India, 1957-2020.
    Chakraborty S; Sander WE; Allan BF; Andrade FCD
    Emerg Infect Dis; 2021 Jul; 27(7):1969-1973. PubMed ID: 34152964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kyasanur forest disease: an epidemiological view in India.
    Pattnaik P
    Rev Med Virol; 2006; 16(3):151-65. PubMed ID: 16710839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute liver failure secondary to severe systemic disease from fatal hemophagocytic lymphohistiocytosis: Case report and systematic literature review.
    Cappell MS; Hader I; Amin M
    World J Hepatol; 2018 Sep; 10(9):629-636. PubMed ID: 30310541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical & epidemiological significance of Kyasanur forest disease.
    Munivenkatappa A; Sahay RR; Yadav PD; Viswanathan R; Mourya DT
    Indian J Med Res; 2018 Aug; 148(2):145-150. PubMed ID: 30381537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Severe Dengue and Associated Hemophagocytic Lymphohistiocytosis in PICU.
    Bhattacharya D; Angurana SK; Nallasamy K; Iyer R; Jayashree M
    Indian J Pediatr; 2019 Dec; 86(12):1094-1098. PubMed ID: 31353429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Study of the Profile of Scrub Typhus in a Tertiary Care Hospital in Jharkhand: An Underestimated Problem.
    Kamath SD; Kumari S; Sunder A
    Cureus; 2022 Jul; 14(7):e26503. PubMed ID: 35923476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A preliminary ecological profile of Kyasanur Forest disease virus hosts among the mammalian wildlife of the Western Ghats, India.
    Walsh MG; Mor SM; Maity H; Hossain S
    Ticks Tick Borne Dis; 2020 Jul; 11(4):101419. PubMed ID: 32241712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
    Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
    Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Profile Study of Japanese Encephalitis in an Industrial Hospital in Eastern India.
    Kamath SD; Jha B; Ahmed T; Sarkar N
    Cureus; 2023 May; 15(5):e38455. PubMed ID: 37273339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemophagocytic lymphohistiocytosis mimicking surgical symptoms and complications: lessons learned from four cases.
    Siminas S; Caswell M; Kenny SE
    J Pediatr Surg; 2013 Jul; 48(7):1514-9. PubMed ID: 23895965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Occupational exposure of cashew nut workers to Kyasanur Forest disease in Goa, India.
    Patil DY; Yadav PD; Shete AM; Nuchina J; Meti R; Bhattad D; Someshwar S; Mourya DT
    Int J Infect Dis; 2017 Aug; 61():67-69. PubMed ID: 28627428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Difference in clinical presentation between the first and second phases of Kyasanur Forest disease: an experience from a teaching hospital in South India.
    Gupta N; Varma M; Saravu K
    Infez Med; 2020 Nov; 28(4):597-602. PubMed ID: 33257636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On the transmission pattern of Kyasanur Forest disease (KFD) in India.
    Murhekar MV; Kasabi GS; Mehendale SM; Mourya DT; Yadav PD; Tandale BV
    Infect Dis Poverty; 2015 Aug; 4():37. PubMed ID: 26286631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kyasanur Forest Disease vaccination coverage and its perceived barriers in Goa, India-A mixed methods operational research.
    Oliveira A; Selvaraj K; Tripathy JP; Betodkar U; Cacodcar J; Wadkar A
    PLoS One; 2019; 14(12):e0226141. PubMed ID: 31891608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.